nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP3A7—Ifosfamide—testicular cancer	0.123	0.177	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.123	0.177	CbGbCtD
Trazodone—CYP3A5—Ifosfamide—testicular cancer	0.0924	0.133	CbGbCtD
Trazodone—ABCB1—Dactinomycin—testicular cancer	0.0509	0.0733	CbGbCtD
Trazodone—CYP3A5—Etoposide—testicular cancer	0.0441	0.0635	CbGbCtD
Trazodone—CYP3A4—Ifosfamide—testicular cancer	0.036	0.0518	CbGbCtD
Trazodone—ABCB1—Vinblastine—testicular cancer	0.0319	0.0459	CbGbCtD
Trazodone—CYP2D6—Vinblastine—testicular cancer	0.03	0.0433	CbGbCtD
Trazodone—ABCB1—Cisplatin—testicular cancer	0.0292	0.0421	CbGbCtD
Trazodone—ABCB1—Etoposide—testicular cancer	0.0287	0.0414	CbGbCtD
Trazodone—ABCB1—Doxorubicin—testicular cancer	0.0196	0.0282	CbGbCtD
Trazodone—CYP3A4—Vinblastine—testicular cancer	0.0191	0.0275	CbGbCtD
Trazodone—ABCB1—Methotrexate—testicular cancer	0.019	0.0273	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—testicular cancer	0.0185	0.0266	CbGbCtD
Trazodone—CYP3A4—Etoposide—testicular cancer	0.0172	0.0248	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—testicular cancer	0.0117	0.0169	CbGbCtD
Trazodone—Hypersensitivity—Dactinomycin—testicular cancer	0.000375	0.00123	CcSEcCtD
Trazodone—Abdominal discomfort—Methotrexate—testicular cancer	0.000372	0.00122	CcSEcCtD
Trazodone—Confusional state—Etoposide—testicular cancer	0.000372	0.00122	CcSEcCtD
Trazodone—Urticaria—Ifosfamide—testicular cancer	0.000371	0.00121	CcSEcCtD
Trazodone—Cardiac arrest—Doxorubicin—testicular cancer	0.00037	0.00121	CcSEcCtD
Trazodone—Abdominal pain—Ifosfamide—testicular cancer	0.000369	0.00121	CcSEcCtD
Trazodone—Body temperature increased—Ifosfamide—testicular cancer	0.000369	0.00121	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000367	0.0012	CcSEcCtD
Trazodone—Ataxia—Doxorubicin—testicular cancer	0.000366	0.0012	CcSEcCtD
Trazodone—Asthenia—Dactinomycin—testicular cancer	0.000365	0.0012	CcSEcCtD
Trazodone—Paraesthesia—Cisplatin—testicular cancer	0.000361	0.00118	CcSEcCtD
Trazodone—Tachycardia—Etoposide—testicular cancer	0.00036	0.00118	CcSEcCtD
Trazodone—Dyspnoea—Cisplatin—testicular cancer	0.000359	0.00117	CcSEcCtD
Trazodone—Erectile dysfunction—Methotrexate—testicular cancer	0.000358	0.00117	CcSEcCtD
Trazodone—Hyperhidrosis—Etoposide—testicular cancer	0.000356	0.00117	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000355	0.00116	CcSEcCtD
Trazodone—Photosensitivity reaction—Methotrexate—testicular cancer	0.000354	0.00116	CcSEcCtD
Trazodone—Anorexia—Etoposide—testicular cancer	0.000351	0.00115	CcSEcCtD
Trazodone—Decreased appetite—Cisplatin—testicular cancer	0.00035	0.00115	CcSEcCtD
Trazodone—Diarrhoea—Dactinomycin—testicular cancer	0.000348	0.00114	CcSEcCtD
Trazodone—Vomiting—Bleomycin—testicular cancer	0.000347	0.00114	CcSEcCtD
Trazodone—Drowsiness—Methotrexate—testicular cancer	0.000346	0.00113	CcSEcCtD
Trazodone—Hypotension—Etoposide—testicular cancer	0.000344	0.00113	CcSEcCtD
Trazodone—Rash—Bleomycin—testicular cancer	0.000344	0.00113	CcSEcCtD
Trazodone—Pain—Cisplatin—testicular cancer	0.000344	0.00113	CcSEcCtD
Trazodone—Dermatitis—Bleomycin—testicular cancer	0.000344	0.00113	CcSEcCtD
Trazodone—Hypersensitivity—Ifosfamide—testicular cancer	0.000344	0.00113	CcSEcCtD
Trazodone—Pollakiuria—Epirubicin—testicular cancer	0.000336	0.0011	CcSEcCtD
Trazodone—Asthenia—Ifosfamide—testicular cancer	0.000335	0.0011	CcSEcCtD
Trazodone—Sweating—Methotrexate—testicular cancer	0.000332	0.00109	CcSEcCtD
Trazodone—Photosensitivity reaction—Epirubicin—testicular cancer	0.000332	0.00109	CcSEcCtD
Trazodone—Feeling abnormal—Cisplatin—testicular cancer	0.000332	0.00109	CcSEcCtD
Trazodone—Paraesthesia—Etoposide—testicular cancer	0.000331	0.00108	CcSEcCtD
Trazodone—Weight increased—Epirubicin—testicular cancer	0.000331	0.00108	CcSEcCtD
Trazodone—Pruritus—Ifosfamide—testicular cancer	0.00033	0.00108	CcSEcCtD
Trazodone—Haematuria—Methotrexate—testicular cancer	0.00033	0.00108	CcSEcCtD
Trazodone—Weight decreased—Epirubicin—testicular cancer	0.000329	0.00108	CcSEcCtD
Trazodone—Dyspnoea—Etoposide—testicular cancer	0.000329	0.00108	CcSEcCtD
Trazodone—Somnolence—Etoposide—testicular cancer	0.000328	0.00107	CcSEcCtD
Trazodone—Nausea—Bleomycin—testicular cancer	0.000324	0.00106	CcSEcCtD
Trazodone—Drowsiness—Epirubicin—testicular cancer	0.000324	0.00106	CcSEcCtD
Trazodone—Vomiting—Dactinomycin—testicular cancer	0.000324	0.00106	CcSEcCtD
Trazodone—Rash—Dactinomycin—testicular cancer	0.000321	0.00105	CcSEcCtD
Trazodone—Decreased appetite—Etoposide—testicular cancer	0.00032	0.00105	CcSEcCtD
Trazodone—Diarrhoea—Ifosfamide—testicular cancer	0.000319	0.00105	CcSEcCtD
Trazodone—Body temperature increased—Cisplatin—testicular cancer	0.000318	0.00104	CcSEcCtD
Trazodone—Fatigue—Etoposide—testicular cancer	0.000318	0.00104	CcSEcCtD
Trazodone—Jaundice—Epirubicin—testicular cancer	0.000316	0.00103	CcSEcCtD
Trazodone—Pain—Etoposide—testicular cancer	0.000315	0.00103	CcSEcCtD
Trazodone—Constipation—Etoposide—testicular cancer	0.000315	0.00103	CcSEcCtD
Trazodone—Sweating—Epirubicin—testicular cancer	0.000311	0.00102	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—testicular cancer	0.000311	0.00102	CcSEcCtD
Trazodone—Haematuria—Epirubicin—testicular cancer	0.000309	0.00101	CcSEcCtD
Trazodone—Dizziness—Ifosfamide—testicular cancer	0.000309	0.00101	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000307	0.001	CcSEcCtD
Trazodone—Weight increased—Doxorubicin—testicular cancer	0.000306	0.001	CcSEcCtD
Trazodone—Weight decreased—Doxorubicin—testicular cancer	0.000304	0.000996	CcSEcCtD
Trazodone—Feeling abnormal—Etoposide—testicular cancer	0.000304	0.000995	CcSEcCtD
Trazodone—Nausea—Dactinomycin—testicular cancer	0.000303	0.000991	CcSEcCtD
Trazodone—Gastrointestinal pain—Etoposide—testicular cancer	0.000301	0.000987	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—testicular cancer	0.0003	0.000982	CcSEcCtD
Trazodone—Visual impairment—Methotrexate—testicular cancer	0.000299	0.000981	CcSEcCtD
Trazodone—Vomiting—Ifosfamide—testicular cancer	0.000297	0.000972	CcSEcCtD
Trazodone—Hypersensitivity—Cisplatin—testicular cancer	0.000296	0.000971	CcSEcCtD
Trazodone—Bradycardia—Epirubicin—testicular cancer	0.000296	0.00097	CcSEcCtD
Trazodone—Rash—Ifosfamide—testicular cancer	0.000294	0.000964	CcSEcCtD
Trazodone—Dermatitis—Ifosfamide—testicular cancer	0.000294	0.000963	CcSEcCtD
Trazodone—Urticaria—Etoposide—testicular cancer	0.000293	0.000959	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—testicular cancer	0.000292	0.000957	CcSEcCtD
Trazodone—Abdominal pain—Etoposide—testicular cancer	0.000291	0.000954	CcSEcCtD
Trazodone—Body temperature increased—Etoposide—testicular cancer	0.000291	0.000954	CcSEcCtD
Trazodone—Tinnitus—Methotrexate—testicular cancer	0.00029	0.000949	CcSEcCtD
Trazodone—Hypoaesthesia—Epirubicin—testicular cancer	0.000289	0.000948	CcSEcCtD
Trazodone—Asthenia—Cisplatin—testicular cancer	0.000289	0.000945	CcSEcCtD
Trazodone—Sweating—Doxorubicin—testicular cancer	0.000287	0.000941	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—testicular cancer	0.000286	0.000936	CcSEcCtD
Trazodone—Visual impairment—Epirubicin—testicular cancer	0.00028	0.000918	CcSEcCtD
Trazodone—Chills—Methotrexate—testicular cancer	0.000279	0.000913	CcSEcCtD
Trazodone—Nausea—Ifosfamide—testicular cancer	0.000277	0.000908	CcSEcCtD
Trazodone—Diarrhoea—Cisplatin—testicular cancer	0.000275	0.000901	CcSEcCtD
Trazodone—Alopecia—Methotrexate—testicular cancer	0.000275	0.000899	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—testicular cancer	0.000274	0.000897	CcSEcCtD
Trazodone—Hypersensitivity—Etoposide—testicular cancer	0.000272	0.000889	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—testicular cancer	0.000271	0.000888	CcSEcCtD
Trazodone—Flushing—Epirubicin—testicular cancer	0.00027	0.000884	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—testicular cancer	0.000268	0.000877	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—testicular cancer	0.000265	0.000868	CcSEcCtD
Trazodone—Asthenia—Etoposide—testicular cancer	0.000264	0.000866	CcSEcCtD
Trazodone—Back pain—Methotrexate—testicular cancer	0.000262	0.000857	CcSEcCtD
Trazodone—Chills—Epirubicin—testicular cancer	0.000261	0.000855	CcSEcCtD
Trazodone—Pruritus—Etoposide—testicular cancer	0.000261	0.000854	CcSEcCtD
Trazodone—Arrhythmia—Epirubicin—testicular cancer	0.00026	0.000851	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—testicular cancer	0.000259	0.000849	CcSEcCtD
Trazodone—Alopecia—Epirubicin—testicular cancer	0.000257	0.000842	CcSEcCtD
Trazodone—Vomiting—Cisplatin—testicular cancer	0.000256	0.000838	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—testicular cancer	0.000255	0.000835	CcSEcCtD
Trazodone—Rash—Cisplatin—testicular cancer	0.000254	0.000831	CcSEcCtD
Trazodone—Dermatitis—Cisplatin—testicular cancer	0.000253	0.00083	CcSEcCtD
Trazodone—Diarrhoea—Etoposide—testicular cancer	0.000252	0.000826	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—testicular cancer	0.000251	0.000822	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—testicular cancer	0.000251	0.000822	CcSEcCtD
Trazodone—Anaemia—Methotrexate—testicular cancer	0.00025	0.000819	CcSEcCtD
Trazodone—Flushing—Doxorubicin—testicular cancer	0.00025	0.000818	CcSEcCtD
Trazodone—Flatulence—Epirubicin—testicular cancer	0.000249	0.000817	CcSEcCtD
Trazodone—Tension—Epirubicin—testicular cancer	0.000248	0.000814	CcSEcCtD
Trazodone—Dysgeusia—Epirubicin—testicular cancer	0.000248	0.000812	CcSEcCtD
Trazodone—Nervousness—Epirubicin—testicular cancer	0.000246	0.000805	CcSEcCtD
Trazodone—Back pain—Epirubicin—testicular cancer	0.000245	0.000802	CcSEcCtD
Trazodone—Malaise—Methotrexate—testicular cancer	0.000244	0.000799	CcSEcCtD
Trazodone—Dizziness—Etoposide—testicular cancer	0.000244	0.000798	CcSEcCtD
Trazodone—Vertigo—Methotrexate—testicular cancer	0.000243	0.000796	CcSEcCtD
Trazodone—Chills—Doxorubicin—testicular cancer	0.000241	0.000791	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—testicular cancer	0.00024	0.000787	CcSEcCtD
Trazodone—Nausea—Cisplatin—testicular cancer	0.000239	0.000783	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—testicular cancer	0.000239	0.000781	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—testicular cancer	0.000238	0.000779	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—testicular cancer	0.000235	0.000769	CcSEcCtD
Trazodone—Vomiting—Etoposide—testicular cancer	0.000234	0.000767	CcSEcCtD
Trazodone—Anaemia—Epirubicin—testicular cancer	0.000234	0.000766	CcSEcCtD
Trazodone—Agitation—Epirubicin—testicular cancer	0.000233	0.000762	CcSEcCtD
Trazodone—Rash—Etoposide—testicular cancer	0.000232	0.000761	CcSEcCtD
Trazodone—Dermatitis—Etoposide—testicular cancer	0.000232	0.00076	CcSEcCtD
Trazodone—Headache—Etoposide—testicular cancer	0.000231	0.000756	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—testicular cancer	0.000231	0.000756	CcSEcCtD
Trazodone—Myalgia—Methotrexate—testicular cancer	0.00023	0.000754	CcSEcCtD
Trazodone—Chest pain—Methotrexate—testicular cancer	0.00023	0.000754	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—testicular cancer	0.00023	0.000754	CcSEcCtD
Trazodone—Tension—Doxorubicin—testicular cancer	0.00023	0.000753	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—testicular cancer	0.000229	0.000751	CcSEcCtD
Trazodone—Malaise—Epirubicin—testicular cancer	0.000228	0.000748	CcSEcCtD
Trazodone—Discomfort—Methotrexate—testicular cancer	0.000228	0.000745	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—testicular cancer	0.000228	0.000745	CcSEcCtD
Trazodone—Vertigo—Epirubicin—testicular cancer	0.000227	0.000745	CcSEcCtD
Trazodone—Syncope—Epirubicin—testicular cancer	0.000227	0.000743	CcSEcCtD
Trazodone—Back pain—Doxorubicin—testicular cancer	0.000227	0.000742	CcSEcCtD
Trazodone—Palpitations—Epirubicin—testicular cancer	0.000224	0.000733	CcSEcCtD
Trazodone—Confusional state—Methotrexate—testicular cancer	0.000223	0.000729	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—testicular cancer	0.000223	0.000729	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—testicular cancer	0.000221	0.000723	CcSEcCtD
Trazodone—Nausea—Etoposide—testicular cancer	0.000219	0.000717	CcSEcCtD
Trazodone—Hypertension—Epirubicin—testicular cancer	0.000219	0.000716	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000217	0.000712	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—testicular cancer	0.000217	0.000709	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—testicular cancer	0.000216	0.000706	CcSEcCtD
Trazodone—Myalgia—Epirubicin—testicular cancer	0.000216	0.000706	CcSEcCtD
Trazodone—Chest pain—Epirubicin—testicular cancer	0.000216	0.000706	CcSEcCtD
Trazodone—Agitation—Doxorubicin—testicular cancer	0.000215	0.000705	CcSEcCtD
Trazodone—Anxiety—Epirubicin—testicular cancer	0.000215	0.000703	CcSEcCtD
Trazodone—Hyperhidrosis—Methotrexate—testicular cancer	0.000213	0.000699	CcSEcCtD
Trazodone—Discomfort—Epirubicin—testicular cancer	0.000213	0.000697	CcSEcCtD
Trazodone—Malaise—Doxorubicin—testicular cancer	0.000211	0.000692	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—testicular cancer	0.000211	0.00069	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—testicular cancer	0.00021	0.000689	CcSEcCtD
Trazodone—Anorexia—Methotrexate—testicular cancer	0.00021	0.000689	CcSEcCtD
Trazodone—Syncope—Doxorubicin—testicular cancer	0.00021	0.000688	CcSEcCtD
Trazodone—Confusional state—Epirubicin—testicular cancer	0.000208	0.000682	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—testicular cancer	0.000207	0.000678	CcSEcCtD
Trazodone—Oedema—Epirubicin—testicular cancer	0.000207	0.000677	CcSEcCtD
Trazodone—Hypotension—Methotrexate—testicular cancer	0.000206	0.000676	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—testicular cancer	0.000206	0.000674	CcSEcCtD
Trazodone—Shock—Epirubicin—testicular cancer	0.000203	0.000666	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—testicular cancer	0.000202	0.000662	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—testicular cancer	0.000202	0.00066	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000201	0.000659	CcSEcCtD
Trazodone—Hyperhidrosis—Epirubicin—testicular cancer	0.0002	0.000654	CcSEcCtD
Trazodone—Insomnia—Methotrexate—testicular cancer	0.0002	0.000654	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—testicular cancer	0.000199	0.000653	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—testicular cancer	0.000199	0.000653	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—testicular cancer	0.000199	0.000653	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—testicular cancer	0.000199	0.000651	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—testicular cancer	0.000198	0.000649	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—testicular cancer	0.000197	0.000645	CcSEcCtD
Trazodone—Anorexia—Epirubicin—testicular cancer	0.000197	0.000645	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—testicular cancer	0.000197	0.000645	CcSEcCtD
Trazodone—Somnolence—Methotrexate—testicular cancer	0.000196	0.000643	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—testicular cancer	0.000195	0.000639	CcSEcCtD
Trazodone—Hypotension—Epirubicin—testicular cancer	0.000193	0.000632	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—testicular cancer	0.000193	0.000631	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—testicular cancer	0.000192	0.000629	CcSEcCtD
Trazodone—Oedema—Doxorubicin—testicular cancer	0.000191	0.000626	CcSEcCtD
Trazodone—Fatigue—Methotrexate—testicular cancer	0.00019	0.000623	CcSEcCtD
Trazodone—Pain—Methotrexate—testicular cancer	0.000189	0.000618	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000188	0.000616	CcSEcCtD
Trazodone—Shock—Doxorubicin—testicular cancer	0.000188	0.000616	CcSEcCtD
Trazodone—Insomnia—Epirubicin—testicular cancer	0.000187	0.000612	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—testicular cancer	0.000187	0.000611	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—testicular cancer	0.000186	0.000608	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000185	0.000605	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—testicular cancer	0.000184	0.000603	CcSEcCtD
Trazodone—Somnolence—Epirubicin—testicular cancer	0.000184	0.000602	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—testicular cancer	0.000182	0.000597	CcSEcCtD
Trazodone—Feeling abnormal—Methotrexate—testicular cancer	0.000182	0.000596	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000181	0.000591	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—testicular cancer	0.00018	0.000588	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—testicular cancer	0.000179	0.000585	CcSEcCtD
Trazodone—Fatigue—Epirubicin—testicular cancer	0.000178	0.000583	CcSEcCtD
Trazodone—Constipation—Epirubicin—testicular cancer	0.000177	0.000579	CcSEcCtD
Trazodone—Pain—Epirubicin—testicular cancer	0.000177	0.000579	CcSEcCtD
Trazodone—Urticaria—Methotrexate—testicular cancer	0.000175	0.000574	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—testicular cancer	0.000175	0.000572	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—testicular cancer	0.000175	0.000572	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000174	0.00057	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—testicular cancer	0.000173	0.000566	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—testicular cancer	0.000172	0.000562	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—testicular cancer	0.00017	0.000558	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—testicular cancer	0.00017	0.000558	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—testicular cancer	0.00017	0.000557	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000169	0.000553	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—testicular cancer	0.000166	0.000544	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—testicular cancer	0.000165	0.00054	CcSEcCtD
Trazodone—Urticaria—Epirubicin—testicular cancer	0.000164	0.000538	CcSEcCtD
Trazodone—Constipation—Doxorubicin—testicular cancer	0.000163	0.000535	CcSEcCtD
Trazodone—Pain—Doxorubicin—testicular cancer	0.000163	0.000535	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—testicular cancer	0.000163	0.000535	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—testicular cancer	0.000163	0.000535	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—testicular cancer	0.000163	0.000533	CcSEcCtD
Trazodone—Asthenia—Methotrexate—testicular cancer	0.000158	0.000519	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—testicular cancer	0.000158	0.000516	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000156	0.000512	CcSEcCtD
Trazodone—Pruritus—Methotrexate—testicular cancer	0.000156	0.000512	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—testicular cancer	0.000152	0.000499	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—testicular cancer	0.000152	0.000497	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—testicular cancer	0.000151	0.000495	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—testicular cancer	0.000151	0.000495	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—testicular cancer	0.000151	0.000495	CcSEcCtD
Trazodone—Asthenia—Epirubicin—testicular cancer	0.000148	0.000485	CcSEcCtD
Trazodone—Pruritus—Epirubicin—testicular cancer	0.000146	0.000479	CcSEcCtD
Trazodone—Dizziness—Methotrexate—testicular cancer	0.000146	0.000478	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—testicular cancer	0.000141	0.000463	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—testicular cancer	0.000141	0.000461	CcSEcCtD
Trazodone—Vomiting—Methotrexate—testicular cancer	0.00014	0.00046	CcSEcCtD
Trazodone—Rash—Methotrexate—testicular cancer	0.000139	0.000456	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—testicular cancer	0.000139	0.000455	CcSEcCtD
Trazodone—Headache—Methotrexate—testicular cancer	0.000138	0.000453	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—testicular cancer	0.000137	0.000449	CcSEcCtD
Trazodone—Dizziness—Epirubicin—testicular cancer	0.000137	0.000447	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—testicular cancer	0.000135	0.000443	CcSEcCtD
Trazodone—Vomiting—Epirubicin—testicular cancer	0.000131	0.00043	CcSEcCtD
Trazodone—Nausea—Methotrexate—testicular cancer	0.000131	0.000429	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—testicular cancer	0.000131	0.000428	CcSEcCtD
Trazodone—Rash—Epirubicin—testicular cancer	0.00013	0.000427	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—testicular cancer	0.00013	0.000426	CcSEcCtD
Trazodone—Headache—Epirubicin—testicular cancer	0.000129	0.000424	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—testicular cancer	0.000126	0.000414	CcSEcCtD
Trazodone—Nausea—Epirubicin—testicular cancer	0.000123	0.000402	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—testicular cancer	0.000122	0.000398	CcSEcCtD
Trazodone—Rash—Doxorubicin—testicular cancer	0.000121	0.000395	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—testicular cancer	0.00012	0.000394	CcSEcCtD
Trazodone—Headache—Doxorubicin—testicular cancer	0.00012	0.000392	CcSEcCtD
Trazodone—Nausea—Doxorubicin—testicular cancer	0.000114	0.000372	CcSEcCtD
